TPR - December 15th., 2012
http://www.thepoisonreview.com/2012/12/15/cpc-alcohol-withdrawal-with-delirium-tremens-and-a-significant-missed-diagnosis/
*
ALiEM - By Bryan Hayer, PharmD | February 7th, 2013
"Alpha-2 agonists that reduce sympathetic output may be effective adjunct treatment modalities without suppressing respiratory drive. Some older studies using clonidine demonstrated possible benefit. There are also several case reports and a small case series using dexmedetomidine (a parenteral alpha-2 agonist). Three larger case series were published in 2012 evaluating dexmedetomidine in this role. FDA-approved dosing is 0.2-0.7 mcg/kg/hr as a continuous infusion"
http://academiclifeinem.com/dexmedetomidine-precedex-as-an-adjunct-to-benzodiazepines-for-ethanol-withdrawal/
*
http://emcrit.org/podcasts/delirium-tremens/